Skip to main content
Caplight Logo









EvolutionaryScale

EvolutionaryScale

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.evolutionaryscale.ai/

Last Round

Seed

Jun 25, 2024

Est. Valuation

$200M

Total Funding Raised

$182M

Company Overview

EvolutionaryScale is a biotechnology company that develops artificial intelligence models to design therapies by predicting protein structures through the integration of biological data, allowing researchers to utilize large language models for creating RNA-based drug therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Revenue Share

AI Layer

Foundation

Keywords

generative biologyprotein designfoundation modeldrug discoverysynthetic biologyprotein language modelbio-aifrontier ai labprotein engineeringgenerative aibiological dataai for sciencebiotech aiapi platformusage-based saas

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EvolutionaryScale Comparables

Compare EvolutionaryScale with similar companies based on industry and business-model similarity.

EvolutionaryScale comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anthrogen
89%
Boltz
88%
BioLM
86%

EvolutionaryScale Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 25, 2024
SeedAug 25, 2023

Key People

Founding team and executive leadership

Luuk van Schijndel

Interim CFO

Executive Team

EvolutionaryScale Investors

Notable investors and investment history

EvolutionaryScale investors
InvestorRounds
Lux CapitalSeed
NVenturesSeed
NVenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 57% MoM, reaching 21K.

  • Nov 3, 2025

    Developing AI models for novel protein generation in scientific research.

EvolutionaryScale Filings

Explore SEC and related filing metadata, where available.

EvolutionaryScale filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EvolutionaryScale's valuation, stock price, and market status.

Is EvolutionaryScale a public or private company?

EvolutionaryScale is a private company.

What is the current stock price of EvolutionaryScale?

EvolutionaryScale is a private company with no public stock price. No recent secondary market data is available.

How much is EvolutionaryScale worth (valuation)?

EvolutionaryScale's valuation is estimated at $200.0M based on funding round data.

Can I buy EvolutionaryScale stock?

EvolutionaryScale shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EvolutionaryScale's last funding round?

EvolutionaryScale's most recent funding round was Seed on August 25, 2023.

Who are the main investors in EvolutionaryScale?

Key investors in EvolutionaryScale include Lux Capital.

Will EvolutionaryScale IPO soon?

No public IPO plans have been announced for EvolutionaryScale.

How can I track EvolutionaryScale secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EvolutionaryScale's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range11
Year Founded2023
Last FundingJun 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?